Counterfeit drugs: defining the problem and finding solutions.
The problem of counterfeit drugs is increasingly becoming a top priority of drug regulatory agencies, licit pharmaceutical manufacturers and healthcare professionals, and is of rising concern among consumers. A review of the current literature reveals that counterfeiting is no longer isolated in developing nations, but is a worldwide pandemic. Although international organisations such as the World Health Organization, have devised specific measures to combat the counterfeit trade, the problem still remains quite daunting. Although the practice of drug counterfeiting is unlikely to ever completely disappear, it may be controlled if governments and all relevant parties combine forces to identify and disrupt the counterfeit chain.
Wertheimer
Albert I
AI
Santella
Thomas M
TM
D004345:Drug Industry; D004348:Drug Labeling; D004335:Drug and Narcotic Control; D006291:Health Policy; D006801:Humans; D004364:Pharmaceutical Preparations / Q000592:standards*; D014944:World Health Organization
D004364:Pharmaceutical Preparations